Brief summary of the agreement
Anyone is free:
· to copy, distribute, and display the work;
· to make derivative works;
· to make commercial use of the work;
Under the following conditions: Attribution
· the original author must be given credit;
· for any reuse or distribution, it must be made clear to others what the license terms of this work are;
· any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above
Author Biographies
Saad Rifki Jai
Service de Chirurgie Viscérale Aile 3, Centre Hospitalier Universitaire Ibn Rochd, Université Hassan II, Casablanca, Maroc
Robleh Hassan Farah
Service de Chirurgie Viscérale Aile 3, Centre Hospitalier Universitaire Ibn Rochd, Université Hassan II, Casablanca, Maroc
Brahim Hamdaoui
Service de Chirurgie Viscérale Aile 3, Centre Hospitalier Universitaire Ibn Rochd, Université Hassan II, Casablanca, Maroc
Rachid Boufettal
Service de Chirurgie Viscérale Aile 3, Centre Hospitalier Universitaire Ibn Rochd, Université Hassan II, Casablanca, Maroc
Farid Chehab
Service de Chirurgie Viscérale Aile 3, Centre Hospitalier Universitaire Ibn Rochd, Université Hassan II, Casablanca, Maroc
Main Article Content
Pleomorphous leiomyosarcoma of the mesocolon: a case report
Saad Rifki Jai
Robleh Hassan Farah
Brahim Hamdaoui
Rachid Boufettal
Farid Chehab
Abstract
Leiomyosarcoma is a rare tumor of the smooth muscle, but relatively frequent in the stomach and the small intestine. The mesocolic site is rare. Globally, leimyosarcoma represents less than 0, 1% of the malignant tumors found in the colon and the anus. Because of the similarities with other digestive tumors, namely mesenchymatous or benign tumors of the smooth muscle, the diagnosis of a pleomorphic sarcoma remains difficult even at the histological stage. Surgery is the mainstay of the therapy. We report a case of leiomyosarcoma of the mesocolon and discuss about its main characteristics in the view of the current literature about this pathological condition.
Pan African Medical Journal 2015; 22
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.